Clinical Trials Logo
  1. Home
  2. Cognition Disorder
  3. NCT06179797

Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study

Cognition Disorder Clinical Trial

Official title:
Chronic Remote Ischemic Conditioning in Vascular Cognitive Impairment: A Dose Escalation Study

Clinical Trial Summary

To evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in patients with age-related cerebral white matter hyperintensities on MRI, in preparation for a subsequent larger efficacy trial.

Clinical Trial Description

Objective: The objective of this early phase study is to evaluate the dose-response of relevant blood biomarkers to remote ischemic conditioning in preparation for a subsequent larger efficacy trial. In addition, we will evaluate the tolerability and adherence to the treatment protocol. Aim: We aim to measure blood biomarkers in response to daily remote ischemic conditioning (RIC) using a dose escalation study design in 40 patients with age-related cerebral white matter hyperintensities on MRI. Hypothesis: We hypothesize that there will be a significant change in the biomarker levels in a dose dependent fashion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06179797
Study type Interventional
Source Augusta University
Contact Askiel Bruno, MD
Phone 706-721-1691
Email abruno@augusta.edu
Status Recruiting
Phase N/A
Start date August 15, 2020
Completion date December 15, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05077501 - Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of ACD856 Phase 1
Recruiting NCT04562844 - Assessment and Rehabilitation of Social Cognition in People With Traumatic Brain Injury N/A
Not yet recruiting NCT05490628 - The Effects of Cognitive Rehabilitation on Motor Performance, Balance and Fear of Falling in Stroke Patients N/A
Active, not recruiting NCT05111275 - Cognitive Exercises in Survivors of a Prolonged ICU Stay. N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Recruiting NCT05464472 - Impact of Transcatheter Aortic Valve Implantation (TAVI) on Cognitive Functions
Not yet recruiting NCT06357195 - DIAMOND-Lewy Guidelines for Antipsychotic Use in Older Patients
Recruiting NCT05886114 - A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China N/A
Withdrawn NCT04019665 - Self-screening of Cognitive Impairment in Primary Care N/A
Completed NCT00240695 - A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment Phase 3
Completed NCT04219774 - NeuroCognition After Carotid Recanalization Phase 2
Not yet recruiting NCT06268080 - Depth of Anesthesia on Postoperative Delirium and Cognitive After Surgery N/A
Completed NCT00695136 - The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism Phase 1/Phase 2
Recruiting NCT04911738 - VIrtual Reality Glasses Use to Improve Lateropulsion and the Post-stroke Postural Vertical N/A
Withdrawn NCT01668758 - fMRI and NIRS Imaging for Traumatic Brain Injury N/A
Completed NCT05783830 - Study Evaluating the Pharmacokinetics of a Single Microdose of ACD856 Early Phase 1
Recruiting NCT06186102 - Polyamine Treatment in Elderly Patients With Coronary Artery Disease Phase 2
Recruiting NCT05322031 - The Impact of Aripiprazole Long-acting on Myelin and Cognition in the Onset of Schizophrenia Phase 4
Completed NCT04210713 - Neuroimmune Dysfunction in Alcohol Use Disorder Phase 1
Completed NCT05077631 - Study to Evaluate the Effects of Single Ascending Oral Doses of ACD856 on Safety, Tolerability and Pharmacokinetics Phase 1